Skip to main content

Posts

Stage 2 of the Toe Lift

Watch video!
Recent posts

12 Week Case Study - Video 2

Today's Toe Lift Patient

Listen to the latest podcast about the toe lift
12 Week Case Study - Video 1
This has been a challenge!

Stage 1 and Stage 2

Amazing results after 2 months!

Post 2 months of treatment!

Stage 2 Injection Today

You can see a huge difference from before stage 1, still needs 3-4 months for full recovered but the process has begun!


After 5 weeks

Notice the lesions have got smaller and the color is only now beginning to change, these toes need another 3-4 months




Today's Toe Lift Patient

Treatment of Scars With Hyaluronic Acid

After 5 months!

This patient is very happy with her toe after 5 months, she can finally wear sandals!

After 2 weeks!

Significant reduction in scar depth after 2 weeks post stage 1 reduction, ready for stage 2!

How do Corticosteroids Reduce Scars?

Today's Toe Lift Patient




1 Month Review!

Is there a consensus for scar treatment?

Scarring and its accompanying esthetic, functional, and psychological sequelae still pose major challenges. To date, there is no satisfactory prevention or treatment option for hyper trophic scars on the tops of toes, which is mostly due to not completely comprehending the mechanisms underlying their formation. However, providing footwear advice is the most logical prevention option but this may not balance with the individuals needs and desires.  A predominant role in hypertrophic scarring prevention and treatment still remains silicone sheeting or gel. The efficacy and safety of this gold-standard, non-invasive therapy has been demonstrated in many clinical studies, but to date, exact mechanisms by which they improve hyper trophic scars are yet to be fully agreed upon. Second most validated and more specialised scar treatment is intralesional corticosteroid injections, especially in combination with other therapeutic modalities. Current therapeutic approaches with their empirical e…

Clinical Scar Evaluation

If a scar forms, regardless of whether or not prophylactic measures were applied, it should be evaluated clinically. When assessing scars clinically, their size, colour, contour, height (thickness), surface area, surface texture, pliability, location, and subjective symptoms such as itching and pain, and also patient’s perception should be taken into account. 
It has been indicated that this subjective component of the patient’s view of the scar is as important as objective aspect and it may be very influential in determining the patient’s quality of life (1). Assessment of the scars is a frequent topic of discussion among clinicians because there is no generally accepted evaluation tool, although various ones have been proposed (2). 
None of these, however, seem suitable as a stand-alone tool, suggesting that combination of objective imaging tools and scar scales and questionnaires (patient reported outcome measures that we use in clinic) may be justified to achieve comprehensive docum…